Underutilization of Aldosterone Antagonists in Heart Failure

Background: Treatment with an aldosterone antagonist (AA) has been shown in multiple trials to reduce heart failure (HF)–related morbidity, mortality, and hospital readmission. American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) treatment guidelines recommend the us...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hosp Pharm
Main Authors: Patterson, Shanise J., Reaves, Anne B., Tolley, Elizabeth A., Ulrich, Dagny, Hilty, Christopher, Clarke, Catherine J., Self, Timothy H.
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2017
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5735744/
https://ncbi.nlm.nih.gov/pubmed/29276242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578717724886
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares